Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice - Wikidata - awgldk - TriplyDB

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

http://www.wikidata.org/entity/Q33905765

about

Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation Monocytes in atherosclerosis: subsets and functions Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II CD36: implications in cardiovascular disease Macrophage-mediated cholesterol handling in atherosclerosis Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development The innate immune response to products of phospholipid peroxidation Generation and biological activities of oxidized phospholipids Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Macrophages in the pathogenesis of atherosclerosis Novel functions of PXR in cardiometabolic disease.Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.Mechanisms by which diabetes increases cardiovascular disease.Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.Mechanisms that regulate macrophage burden in atherosclerosis.CD36, a scavenger receptor implicated in atherosclerosis.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.You are right too!Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling.Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation.

P2860

Q21558503-D4856D8D-AECA-4A97-8CE8-4EA7E327E752 Q22251045-ED22769E-CE52-416C-8E32-3BBE779060B5 Q24631660-4A424526-1821-46AE-80F6-93DC49D90A3F Q24634165-D30A2CF0-A184-4B6B-A3DD-3C002139B278 Q24642646-AE08FC36-EAF4-48BE-A54F-925BD591D6A9 Q24658096-3A33E9DC-C6DF-42A6-85E6-C3C161E65E65 Q24678338-56B56040-BA54-42D3-B15E-48D235FFC89B Q26780405-1A3ACA06-5178-43B4-9F89-1E3E30BECF46 Q26799114-C941C1DD-F809-45B8-A649-AD09DD97DD68 Q26822962-1F603485-6B6F-46AB-A2B8-61DEBD7AB8AA Q27309881-F120BAE6-18F0-4342-86C5-96B3B2300344 Q28219857-0FAEFE62-0257-4B43-B39C-4894F41A047B Q28255651-97E73B4D-9EFC-4BD3-9DDE-843E90F153A0 Q28260242-58538664-06CA-4132-B6B0-BB12491F1BDB Q28389385-512C4889-C1E0-4F77-B3BF-8F9281E5C6A2 Q28389691-E810F211-2018-430D-B9C4-10FE3D993F43 Q28506019-C295EE1E-A9D3-4F15-ADDB-F98B26C8F4C6 Q28506359-15829114-C7F3-435E-8A29-ED6013AECEAB Q28506984-E9F43B08-C457-42FE-8035-F6E83A845F7C Q28511467-BE833136-A194-4F84-816F-C6C1DC9F4C6F Q28729175-B639C0E4-35DE-4F86-AAAA-89141AA17D5F Q29615704-9145A980-8DA0-4E66-BE72-309B3623D5E0 Q29617765-2F70F035-D8AD-4BD3-9A86-31289BB96680 Q30251861-9742E524-9EEF-4BD0-9513-05CCA4BDC794 Q30436299-C4400D65-DEA9-42FE-A1A4-B0327AF43CF2 Q30441275-99849A16-9633-44E8-9F75-F6661F5605C2 Q30559538-6094EE42-D721-452D-8851-0C1BAFBA1474 Q33547771-C8ECF77F-4DF5-49E5-ACC2-D52181AD1E6C Q33552642-DAC34D9F-7A0C-454E-87A0-4C2E1C94DA32 Q33609100-EC613FBE-0623-479A-8663-499F500A0CEE Q33641499-DA6A89FC-7743-45D9-BEDA-D835BA48CE2B Q33653519-7CC5D174-B1E5-40B8-9897-37A13B51F591 Q33697097-87E9B7A8-54EB-42F0-9E3F-37C7B85BD98F Q33752256-E212DFE2-3899-48A8-A0DE-9E51EA579B9B Q33761114-5CC1B695-C57D-42CA-A2CC-95FB4A4F20C1 Q33844864-5E4E74B6-C166-4C50-82D3-612B9CA9F45B Q33879138-B3C1D5DC-E467-4E73-AFD0-BB5912EEA4E1 Q33905863-189B97D1-9EE0-4001-ABA5-1F8523E504F8 Q33908017-F6ADD6BA-E4DD-4E3A-857E-C3319821678F Q33945076-064AC08B-F036-44D7-840F-E8D5144D7590

P2860

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

http://www.wikidata.org/entity/Q33905765

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@ast

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@en

type

label

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@ast

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@en

prefLabel

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@ast

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@en

P1433

Q33905765-6E3D5D2A-C36A-4A99-B287-CFA8991090D4

P1476

Q33905765-D95D9641-0B08-4101-A5C5-18996585BF22

P2093

Q33905765-0789FF77-2113-4E31-9B59-E0C1CB4B6326

Q33905765-300545E0-929B-44E5-8F31-D6A58F68D60C

Q33905765-4D3C03F6-3351-41D4-A453-9EA5D69AC26F

Q33905765-4EE6ED7E-3FDC-4B61-BCF3-BD6B8E92FA8A

Q33905765-81DE6C92-94A8-4BE3-9DA8-A61777B88F54

Q33905765-C7E3540E-4FB5-4A58-BB4F-70E57A4A9C36

Q33905765-E649242F-1AC8-4A7F-AE42-22780090CFDF

Q33905765-FDDC9A69-AE26-4A2C-AEA3-F78EACCC930E

P2860

Q33905765-0C861B3C-4DF9-427F-BD9C-3CFCEFBCB982

Q33905765-0D169ADD-0A25-4A22-B1C1-5F5E5847B7F5

Q33905765-12DD7352-885B-4391-B4DC-DC15197ED8D7

Q33905765-1707B973-9FEE-431F-AFA2-474B46D38964

Q33905765-1C06443C-1659-45F8-81CF-78151323A6D1

Q33905765-28189891-E532-4163-9803-4A89750DD8FC

Q33905765-2948F75D-D608-49EF-B001-B5053B0CD482

Q33905765-2AB470FF-E66A-435A-8CCE-160B65476FFC

Q33905765-2B1C7667-2FEC-4E4A-AEF0-7C9FB3DEE32C

Q33905765-2B62DD02-5D6F-4070-8C41-9D63C095C5CD

P304

Q33905765-9BC15E0B-2AE3-44E1-AC43-32A0547DAD49

P31

Q33905765-7AEFEDFB-62BE-4F3A-890C-859F70996A60

P356

Q33905765-40DA9A0A-D44D-4B17-9698-46AD606F56A6

P407

Q33905765-B0F6454D-0A97-4545-848B-1B47B1CFEC96

P433

Q33905765-0A9DB0E3-F169-4953-B575-F625D707FE0C

P478

Q33905765-DB24C24E-1581-434E-A205-9DA9B91F827D

P577

Q33905765-E9FB6896-67CB-4254-B71D-ED5AC16DC462

P698

Q33905765-6CDFB376-A84A-4E5C-B024-F9F7082368DC

P921

Q33905765-5670718A-77BE-445B-9799-6CC87B0548D5

Q33905765-F71DB25C-0248-462F-81A4-A456202C9037

P932

Q33905765-5452BE58-38A8-48D9-9590-2B7CDD32301F

P356

P1433

Journal of Clinical Investigation

P1476

Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice

@en

P2093

Anita A Tseng

http://www.w3.org/2001/XMLSchema#string

Jennifer J Manning

http://www.w3.org/2001/XMLSchema#string

Jessica M Silver

http://www.w3.org/2001/XMLSchema#string

Kathryn J Moore

http://www.w3.org/2001/XMLSchema#string

Mary McKee

http://www.w3.org/2001/XMLSchema#string

Mason W Freeman

http://www.w3.org/2001/XMLSchema#string

Stephanie L Koehn

http://www.w3.org/2001/XMLSchema#string

Vidya V Kunjathoor

http://www.w3.org/2001/XMLSchema#string

P2860

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

The response-to-retention hypothesis of early atherogenesis

CD36 is a receptor for oxidized low density lipoprotein

Macrophage foam cells and atherosclerosis.

Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis.

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

P304

2192-2201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24061

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16075060

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

1180534

http://www.w3.org/2001/XMLSchema#string